Steven Rohrbeck is a Cardiology physician affiliated with Medicines Company. OpenAlex indexes 10 publications with 1,234 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
306 Westwood Ave
Suite 401
High Point, NC 272624341
Telephone
336-885-6168Provider last certified this registry record 31 Aug 2021.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202514 payments
- ABIOMEDProgram year20254 payments
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.3%Beta blocker23.9%Metoprolol Succinate52%Carvedilol24%Metoprolol Tartrate19%Atenolol5%Part D≥138 patientsStatin18.9%Atorvastatin Calcium69%Rosuvastatin Calcium22%Pravastatin Sodium7%Simvastatin3%Part D<11 patients+ 14 more classes in this area
Blood & clotting
15.1%Factor Xa inhibitor8.1%Eliquis77%Xarelto23%Part D≥55 patientsP2Y12 inhibitor7%Clopidogrel72%Brilinta21%Prasugrel Hcl7%Part D<11 patientsMetabolism & gastrointestinal
0.6%Potassium supplement0.6%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology
2017 - CAROLINA CHEST PAIN TRACKING PROTOCOL SAFELY REDUCES CARDIOVASCULAR INPATIENT TESTING AND MANAGEMENT COSTS
Journal of the American College of Cardiology
2013 - A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial
Journal of the American College of Cardiology
1999 - Rescue Angioplasty After Failed Thrombolysis: Technical and Clinical Outcomes in a Large Thrombolysis Trial
Journal of the American College of Cardiology
1998 - Gender and Acute Myocardial Infarction: Is There a Different Response to Thrombolysis?
Journal of the American College of Cardiology
1997
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”